Literature DB >> 27135912

Pan-Cancer Analysis of Mutation Hotspots in Protein Domains.

Martin L Miller1, Ed Reznik2, Nicholas P Gauthier2, Bülent Arman Aksoy2, Anil Korkut2, Jianjiong Gao2, Giovanni Ciriello2, Nikolaus Schultz2, Chris Sander3.   

Abstract

In cancer genomics, recurrence of mutations in independent tumor samples is a strong indicator of functional impact. However, rare functional mutations can escape detection by recurrence analysis owing to lack of statistical power. We enhance statistical power by extending the notion of recurrence of mutations from single genes to gene families that share homologous protein domains. Domain mutation analysis also sharpens the functional interpretation of the impact of mutations, as domains more succinctly embody function than entire genes. By mapping mutations in 22 different tumor types to equivalent positions in multiple sequence alignments of domains, we confirm well-known functional mutation hotspots, identify uncharacterized rare variants in one gene that are equivalent to well-characterized mutations in another gene, detect previously unknown mutation hotspots, and provide hypotheses about molecular mechanisms and downstream effects of domain mutations. With the rapid expansion of cancer genomics projects, protein domain hotspot analysis will likely provide many more leads linking mutations in proteins to the cancer phenotype.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Year:  2015        PMID: 27135912      PMCID: PMC4982675          DOI: 10.1016/j.cels.2015.08.014

Source DB:  PubMed          Journal:  Cell Syst        ISSN: 2405-4712            Impact factor:   10.304


  58 in total

1.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

Review 2.  Forkhead transcription factors: key players in development and metabolism.

Authors:  Peter Carlsson; Margit Mahlapuu
Journal:  Dev Biol       Date:  2002-10-01       Impact factor: 3.582

3.  A structural basis for mutational inactivation of the tumour suppressor Smad4.

Authors:  Y Shi; A Hata; R S Lo; J Massagué; N P Pavletich
Journal:  Nature       Date:  1997-07-03       Impact factor: 49.962

Review 4.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

5.  Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis.

Authors:  N Ohtaki; A Yamaguchi; T Goi; T Fukaya; K Takeuchi; K Katayama; K Hirose; T Urano
Journal:  Int J Oncol       Date:  2001-02       Impact factor: 5.650

6.  The Pfam protein families database.

Authors:  Marco Punta; Penny C Coggill; Ruth Y Eberhardt; Jaina Mistry; John Tate; Chris Boursnell; Ningze Pang; Kristoffer Forslund; Goran Ceric; Jody Clements; Andreas Heger; Liisa Holm; Erik L L Sonnhammer; Sean R Eddy; Alex Bateman; Robert D Finn
Journal:  Nucleic Acids Res       Date:  2011-11-29       Impact factor: 16.971

7.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Authors:  Laura Pasqualucci; David Dominguez-Sola; Annalisa Chiarenza; Giulia Fabbri; Adina Grunn; Vladimir Trifonov; Lawryn H Kasper; Stephanie Lerach; Hongyan Tang; Jing Ma; Davide Rossi; Amy Chadburn; Vundavalli V Murty; Charles G Mullighan; Gianluca Gaidano; Raul Rabadan; Paul K Brindle; Riccardo Dalla-Favera
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

8.  Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.

Authors:  Jeffrey C Lee; Igor Vivanco; Rameen Beroukhim; Julie H Y Huang; Whei L Feng; Ralph M DeBiasi; Koji Yoshimoto; Jennifer C King; Phioanh Nghiemphu; Yuki Yuza; Qing Xu; Heidi Greulich; Roman K Thomas; J Guillermo Paez; Timothy C Peck; David J Linhart; Karen A Glatt; Gad Getz; Robert Onofrio; Liuda Ziaugra; Ross L Levine; Stacey Gabriel; Tomohiro Kawaguchi; Keith O'Neill; Haumith Khan; Linda M Liau; Stanley F Nelson; P Nagesh Rao; Paul Mischel; Russell O Pieper; Tim Cloughesy; Daniel J Leahy; William R Sellers; Charles L Sawyers; Matthew Meyerson; Ingo K Mellinghoff
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

9.  Functional impact bias reveals cancer drivers.

Authors:  Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Nucleic Acids Res       Date:  2012-08-16       Impact factor: 16.971

10.  Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers.

Authors:  Jüri Reimand; Gary D Bader
Journal:  Mol Syst Biol       Date:  2013       Impact factor: 11.429

View more
  46 in total

1.  Comparison of algorithms for the detection of cancer drivers at subgene resolution.

Authors:  Eduard Porta-Pardo; Atanas Kamburov; David Tamborero; Tirso Pons; Daniela Grases; Alfonso Valencia; Nuria Lopez-Bigas; Gad Getz; Adam Godzik
Journal:  Nat Methods       Date:  2017-07-17       Impact factor: 28.547

Review 2.  Functional variomics and network perturbation: connecting genotype to phenotype in cancer.

Authors:  Song Yi; Shengda Lin; Yongsheng Li; Wei Zhao; Gordon B Mills; Nidhi Sahni
Journal:  Nat Rev Genet       Date:  2017-03-27       Impact factor: 53.242

3.  An Atlas of the Human Kinome Reveals the Mutational Landscape Underlying Dysregulated Phosphorylation Cascades in Cancer.

Authors:  Aleksandra Olow; Zhongzhong Chen; R Hannes Niedner; Denise M Wolf; Christina Yau; Aleksandr Pankov; Evelyn Pei Rong Lee; Lamorna Brown-Swigart; Laura J van 't Veer; Jean-Philippe Coppé
Journal:  Cancer Res       Date:  2016-02-26       Impact factor: 12.701

4.  Integrated structural and evolutionary analysis reveals common mechanisms underlying adaptive evolution in mammals.

Authors:  Greg Slodkowicz; Nick Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

Review 5.  Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology.

Authors:  Yongsheng Li; Yunpeng Zhang; Xia Li; Song Yi; Juan Xu
Journal:  Trends Biochem Sci       Date:  2019-04-29       Impact factor: 13.807

6.  Decreased FOXJ1 expression and its ciliogenesis programme in aggressive ependymoma and choroid plexus tumours.

Authors:  Malak S Abedalthagafi; Michael P Wu; Parker H Merrill; Ziming Du; Terri Woo; Shu-Hsien Sheu; Shelley Hurwitz; Keith L Ligon; Sandro Santagata
Journal:  J Pathol       Date:  2016-03       Impact factor: 7.996

Review 7.  The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine.

Authors:  Kivilcim Ozturk; Michelle Dow; Daniel E Carlin; Rafael Bejar; Hannah Carter
Journal:  J Mol Biol       Date:  2018-06-15       Impact factor: 5.469

Review 8.  Precision Oncology: The Road Ahead.

Authors:  Daniela Senft; Mark D M Leiserson; Eytan Ruppin; Ze'ev A Ronai
Journal:  Trends Mol Med       Date:  2017-09-05       Impact factor: 11.951

9.  Passenger Hotspot Mutations in Cancer.

Authors:  Julian M Hess; Andre Bernards; Jaegil Kim; Mendy Miller; Amaro Taylor-Weiner; Nicholas J Haradhvala; Michael S Lawrence; Gad Getz
Journal:  Cancer Cell       Date:  2019-09-16       Impact factor: 31.743

10.  A domain damage index to prioritizing the pathogenicity of missense variants.

Authors:  Hua-Chang Chen; Jing Wang; Qi Liu; Yu Shyr
Journal:  Hum Mutat       Date:  2021-08-15       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.